Tania de Jong AM on Speak with Courage
Speak with Courage! Podcast, January 31, 2024
Our Executive Director, Tania de Jong AM, discusses our work with Mind Medicine Australia.
The first patient treated in 50 years interviewed by Phillip Adams
ABC Radio - Light Night Live with Phillip Adams, January 30, 2024
Phillip Adams interviews Dr Eli Kotler and the first patient treated with MDMA therapy after 50 years in Australia.
The interview starts at 13 minutes.
Group approach may increase accessibility to psychedelic therapy
ANU College of Health & Medicine, January 23, 2024
Evidence continues to build for the use of psychedelic agents, such as psilocybin and MDMA, to treat depression, anxiety, trauma and OCD. Each therapy session takes six or more hours. This approach can create cost barriers to accessing treatment. In a bid to increase accessibility, a new study by the Australian National University (ANU) School of Medicine and Psychology will look into the viability of the application of psychedelics in a group setting. The study will run over a three-year period with funding by Mind Medicine Australia.
Melbourne mental health patients receive world-first treatment
9 News Australia, January 21, 2024
In what’s being hailed as a world first, mental health patients in Melbourne have been treated with magic mushrooms for psychedelic drug therapy
The ancient remedy achieving a year’s worth of therapy in a day
7 News Australia, January 20, 2024
Melbourne has become the first place in the world where magic mushrooms and MDMA can be prescribed for severe mental health conditions. The first patients began the treatment this week and their doctors have been shocked by the results.
‘Historic moment’: How world leading psychedelic drug therapy started in Melbourne this week
Herald Sun, January 20, 2024
In what’s being hailed a world first, mental health patients have received psychedelic drug treatment with MDMA or psilocybin — better known as magic mushrooms — in Melbourne this week.
Psychiatrists give the First Psychedelic Medicine Dosing Sessions in Clinical Settings in 50 Years this Week in Melbourne Australia
Mind Medicine Australia, January 19, 2024
This week the first two patients received treatment with psychedelic-assisted therapies as part of the Therapeutic Goods Administration’s (TGA) Authorised Prescriber (AP) program in Melbourne, Australia with medicines and training supplied through Mind Medicine Australia.
From the Heart
Peninsula Essence, December 1, 2023
Tania de Jong AM, Mind Medicine Australia Executive Director, is featured in this article. “These transformational therapies will improve the lives of millions of people” she says.
Australia leading the way in psychedelic therapies | 7 News Australia
7 News, October 31, 2023
Leading Psychiatrist and Researcher, Dr Ben Sessa (UK) is currently in Australia overseeing the Certificate in Psychedelic-Assisted Therapies (CPAT) to CPAT training programs for psychiatrists, doctors, psychologists and other practitioners. Please join us for his upcoming public lectures and workshops: https://mindmedicineaustralia.org.au/dr-ben-sessa-uk-australian-tour-2023/
Pioneering Psychedelic Healing and Empowering Voices for Change
Psychedelic Healing Podcast, October 13, 2023
Our Executive Director shares about the work we do at Mind Medicine Australia and how psychedelic-assisted therapies can address the growing mental health crisis.
The Antidepressant Story
ABC News, September 6, 2023
Around one in seven Australians now take some sort of antidepressant. Globally they have made the pharmaceutical industry billions of dollars. While many people say they have benefited from taking them, this week’s Four Corners from the BBC’s Panorama reveals the physical and mental side effects of the drugs can be wide-ranging and are often downplayed.
Psychedelics for Certain Mental Health Conditions ‘World First’, Say Founders of Mind Medicine Australia
The Epoch Times, August 29, 2023
The use of psychedelics for PTSD and drug-resistant depression has gained attention in recent months following the reclassification by Australia’s Therapeutic Goods Administration (TGA) from category nine to category eight.
Breaking Boundaries: Medical Psychedelics
FN Arena, August 21, 2023
Australian companies are establishing themselves in the emerging market of medical psychedelics after Australia became the first country in the world to legalize the use of psychedelics for mental illness.
Podcast: Australia medicalises MDMA and psilocybin with Peter Hunt
The Drug Science Podcast Episodes, August 2, 2023
In this episode, Peter Hunt AM discusses the journey which led himself and his wife co-founding Mind Medicine Australia. Delving into the heart of their mission, Peter explores the groundbreaking potential of psychedelic-assisted treatments in addressing a wide range of mental illnesses. He delves into a comprehensive discussion of the recent developments surrounding the rescheduling of psilocybin in Australia. Trigger Warning: Sexual assault and rape
ANU prepares to launch world-first registry to monitor impacts of psychedelics prescriptions
Riot Act, July 29, 2023
A team from the ANU has developed a world-first registry to track the effectiveness, safety and further development of psychedelic drugs to be used in the treatment of serious mental health conditions. This has been funded by Mind Medicine Australia.
Australia Becomes World’s First Country To Legalise MDMA & Magic Mushrooms For Mental Health
Curly Tales, July 10, 2023
Australia has now become the world’s first country to legalise MDMA and magic mushrooms also called psilocybin officially. Australian psychiatrists in partnership with Optimi Health can receive these drugs supplied by Mind Medicine Australia.
How magic mushrooms saved my life
Cape Talk Radio, July 9, 2023
Psilocybin, also known as magic mushrooms, has been legalised along with MDMA in Australia. It’s just over a week since Australia became the first country in the world to classify psychedelics as medicines at a national level. Mind Medicine Australia executive officer Scott Edwards, the organisation which applied for the rescheduling to classify psychedelics as medicines, said the therapy is being strictly regulated.
A first-of-its-kind patient registry in Australia
ANU Press Release, July 7, 2023
A first-of-its-kind patient registry in Australia will help inform the effectiveness and safety of prescribing psychedelic substances, as part of a therapeutic process, to patients with serious mental health conditions including depression and post-traumatic stress disorder (PTSD). A world-first, the Pharmacotherapy and Psychedelic registry will be developed and led by researchers at The Australian National University (ANU). The registry is supported by the National Health and Medical Research Council and Mind Medicine Australia.
What to consider as we embrace medicinal psychedelics
Hospital & Healthcare, July 3, 2023
After decades of little innovation with new treatment options, Australia’s mental health sector is experiencing a major paradigm shift, with the introduction of medicinal psychedelics. For many clinicians and their patients, the introduction of psychedelic medicine is a welcome move, with remission rates for common mental health conditions having remained stubbornly low for decades. Peter Hunt, Co-founder of mental health charity Mind Medicine Australia, said that with one in five Australian adults living with chronic mental illness, the move to new treatment options can’t come soon enough.
Australia legalises psychedelics for medical use
Bangkok Post, July 1, 2023
“It’s a game-changer for psychiatry in that it’s one of the biggest evolutions in the past 70 years,” said Mike Musker, an enterprise fellow in the mental health and suicide prevention research and education.